and other mood-related conditions.
In 2005, the group that carried out the current study determined the structure 5 of LeuT, a bacterial relative of SERT. LeuT is involved in nutrient uptake in these unicellular organisms and functions similarly to SERT. In 2013, the same group also solved the structure of DAT in fruit flies 6 . This study suggested that the structural organization of these proteins is highly evolutionarily conserved, and defined several structural elements that indicated that the mechanism by which NSSs transport their substrates is also conserved. In providing molecular insights into the structure of human SERT, the current study confirms that nature, when it finds a way to do something, does it over and over again. But in the case of SERT, there is an interesting twist.
To solve structures at high resolution using X-ray crystallography, proteins must be purified in large quantities. Membrane-spanning proteins are notoriously difficult to purify, because they are unstable once removed from the hydrophobic-bilayer environment of the membrane. Previously, membrane proteins have been successfully stabilized by introducing mutations, by inducing the formation of a complex with easily crystallized proteins, or even by developing stabilizing antibodies to the native proteins 7 . Coleman et al. used an elaborate screen to painstakingly identify a few amino-acid residues that could be mutated to stabilize purified SERT without markedly affecting its functional properties. The resulting crystals revealed that the more than 600 amino-acid residues of SERT thread through the cell membrane 12 times to form an intricate 3D structure that is designed to mediate ion-coupled neurotransmitter transport across membranes.
The authors used X-ray crystallography to determine two structures of SERT bound to an SSRI -either paroxetine (Paxil) or escitalopram (Lexapro; the S-enantiomer of citalo pram). As expected from the structure of fruit-fly DAT, they found that one molecule of paroxetine bound tightly in a central cavity in SERT that lies deep within the plasma membrane and is also thought to bind serotonin, thus competitively blocking serotonin transport. However, two molecules of escitalopram bound to SERT: one, like paroxetine, in the high-affinity central cavity, and the second more loosely in an outward-facing external vestibule (Fig. 1) .
The existence of a second binding site (known as an allosteric site) away from SERT's primary binding site was proposed more than 30 years ago 8 . In 2012, modelling and mutational experiments 9 suggested that the site was situated in the external vestibule, as Coleman et al. now confirm. The previous studies suggested that, when present at sufficiently high concentrations, escitalopram binding in the allosteric site could markedly retard the dissociation of drugs bound to the high-affinity site -thus prolonging the SERT-blocking activity of escitalopram. This 'positive allosteric modifier' phenomenon has been proposed to explain the superior clinical efficacy of escitalopram compared with other SSRIs 10 , but confirming the mechanism in animal studies has been difficult 11 . Coleman and colleagues' molecular documentation of the allosteric site is therefore important, because their structure might provide previously unappreciated opportunities for selective drug development.
The presence of allosteric sites on membrane proteins might be more common than anticipated. An example of the possible power of this finding comes from G-protein-coupled receptors (GPCRs) -membrane proteins that bind serotonin, dopamine, noradrenaline and many other signalling molecules on postsynaptic neurons. Successful determination of the structures of more than two dozen of these receptors has identified many potential allosteric binding sites that are being leveraged to help develop positive or negative modifiers of signalling to combat disease 12 . The same opportunity could now present itself for transporters. Visualization of the molecular dynamics of transporter function, coupled with structure-based molecular modelling of drug binding, offers unprecedented opportunities for developing improved treatments for disorders of the central nervous system. ■ 
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B E N N E T T H . P E N N & J E F F E R Y S . C OX
T he ability of mammalian cells to recognize and respond to pathogenic invaders at the earliest stages of infection is crucial for immunity. Many host-cell receptors have been identified that recognize evolutionarily conserved microbial components, such as cell-wall peptidoglycan, to rapidly activate the innate immune system 1 . In this issue, Keestra-Gounder et al. 2 (page 394) describe a curious connection whereby stress in the endoplasmic reticulum (ER), a membrane-bound compartment responsible for the synthesis of secreted cytokine proteins, triggers a cytoplasmic 'danger' signal leading to the release of inflammatory proteins that activate an innate immune response. Even more surprisingly, this ER stress signal is transduced through NOD1 and NOD2 -sensors that respond to fragments of bacterial peptidoglycans -yet takes place in the absence of these molecules.
A wide variety of pathogens hijack and/or manipulate the ER of host cells 3 . Such infection often activates the stress-responsive control system of this organelle, termed the unfolded protein response (UPR) 4, 5 . Previous work indicates that activation of IRE1α, a transmembrane kinase enzyme required for the UPR, leads to inflammation, although the mechanisms involved remain unclear 6, 7 . To avoid triggering the immune response, several bacterial pathogens actively inhibit the UPR 3 . By contrast, Brucella abortus, a bacterial pathogen that causes septic abortion in livestock, and which occasionally infects humans through contaminated dairy products, actively promotes UPR-induced inflammation through its secreted effector protein VceC (ref. 8).
Keestra-Gounder et al. demonstrate that blocking either ER stress or the activity of the stress sensor IRE1α during infection with B. abortus in mice markedly lowered production of the cytokine IL-6 and other mediators of inflammation. Conversely, triggering the UPR in mouse macrophage cells, either with chemical inducers or by expressing the B. abortus VceC protein, resulted in IL-6 release. However, a major twist came when the researchers investigated the mechanism by which the UPR triggered IL-6 release and identified the requirement for NOD1 and NOD2. Keestra-Gounder and colleagues found that genetic inactivation of both receptors, or deletion of the downstream enzyme RIP2, greatly reduced cytokine signalling in response to ER stress. Importantly, these sensors were activated in the absence of bacterial ligands, implying that NOD receptors can participate in both bacterial-ligand-dependent and -independent inflammatory responses (Fig. 1) .
The authors then investigated UPR-mediated inflammation in B. abortus infection in vivo. When they treated pregnant mice infected with B. abortus with the bile salt TUDCA, a chemical used to mitigate the effects of ER stress, they observed dramatically damped inflammation in the placenta, and increased survival of newborn pups, without a change in the bacterial burden. B. abortus is usually transmitted between animals when a pregnant female becomes infected, develops placental inflammation and has a spontaneous abortion, releasing the infected uterine contents. Animals grazing nearby subsequently eat these infected tissues and become infected. The finding that B. abortus secretes a protein that actively triggers placental inflammation suggests that it may be hijacking a host inflammatory pathway to promote its transmission to the next host.
The mechanism by which IRE1α promotes inflammatory signalling remains unresolved. The authors propose a simple model in which IRE1α stimulation leads to the formation of a complex between TRAF2 (a ubiquitin ligase enzyme that binds to IRE1α), NOD1 and NOD2 (Fig. 1) . This then leads to RIP2 activation, presumably by promoting interactions between these proteins. Although this is consistent with the requirement for TRAF2, NODs and RIP2 for inflammatory responses, the question of how the NOD receptors would be activated in the absence of bacteriumderived ligands remains untested. Although NODs have long been known to have a role in peptidoglycan sensing, only more recently have data emerged showing that peptidoglycan can directly bind NOD proteins 9 . It is possible that the peptidoglycan-independent signalling triggered by ER stress activates NODs through a distinct biochemical mechanism. An intriguing alternative possibility is that host-derived ligands are generated in response to ER stress, and activate NOD receptors in the cytoplasm.
Despite these uncertainties, KeestraGounder and colleagues' work compels researchers in the field to expand their thinking about the role of NODs in innate immunity beyond simply the sensing of bacterial ligands. It has long been recognized that the immune response to pathogens in plants relies in part on the monitoring of several normal host-cell physiological processes, and that disruption of these processes by a pathogen triggers an immune response 10 . It is now becoming increasingly evident that mammalian innate immunity also uses this strategy to 'guard' multiple cellular nodes commonly perturbed by pathogens; these include translation 11, 12 , membrane integrity 13 , mitochondrial function 14 , ER homeostasis 3 and cytoskeletal integrity 15 . Strikingly, both the ER and cytoskeletal danger signals are relayed by the NODs in a ligand-independent manner, allowing NODs to participate in sensing a broad range of pathogens 2, 16 . This ligand-independent NOD signalling also has potential implications for human health beyond the realm of infectious diseases. Several common chronic diseases, including type 2 diabetes and inflammatory bowel disease, are associated with ER stress and inflammation 2 show that the cellular state known as endoplasmic reticulum (ER) stress, which is induced by various bacterial infections, generates a danger signal that is also transmitted by NOD proteins, even in the absence of bacterial products. The authors propose that ER stress stimulates the activity of the enzyme IRE1α and leads to the formation of a complex between the enzyme TRAF2 and NOD1 and NOD2, initiating inflammation through RIP2 activation. When combined with previous observations that perturbations of the cytoskeleton, a common target of intracellular bacterial pathogens, may also signal through NODs to trigger inflammation 15, 17 , a model emerges in which NODs serve as a central hub for relaying signals that emanate directly from bacterial ligands and from stress pathways that indirectly detect pathogen attack on the cell.
